No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CDLX240719P9000
- 0.67
- +0.37+123.33%
15min DelayClose Jul 19 16:00 ET
0.67High0.67Low
0.67Open0.30Pre Close2 Volume82 Open Interest9.00Strike Price134.00Turnover1049.45%IV1.42%PremiumJul 19, 2024Expiry Date0.55Intrinsic Value100Multiplier0DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.7113Delta0.3904Gamma12.07Leverage Ratio-4.2723Theta0.0000Rho-8.59Eff Leverage0.0003Vega
Intraday
- 5D
- Daily
News
Express News | Cardlytics Inc : BofA Global Research Reinstates Coverage With Neutral Rating; Price Objective $11
Cardlytics Price Target Announced at $11.00/Share by B of A Securities
Cardlytics Price Target Announced at $11.00/Share by B of A Securities
Express News | B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
BofA Securities Initiates Cardlytics(CDLX.US) With Hold Rating, Announces Target Price $11
BofA Securities analyst Omar Dessouky initiates coverage on $Cardlytics(CDLX.US)$ with a hold rating, and sets the target price at $11.According to TipRanks data, the analyst has a success rate of 45.
Express News | Cardlytics Inc : Northland Capital Initiates Coverage With Outperform Rating; Target Price $14
Cardlytics Initiated at Outperform by Northland Capital Markets
Cardlytics Initiated at Outperform by Northland Capital Markets
Comments
$Cardlytics(CDLX.US$ DEMON NET 🤔
$Cardlytics(CDLX.US$ 15 tonight!!
Cardlytics' unique position with access to large datasets could be a boon as AI adoption progresses. Its acquisition of Dosh is expected to strengthen its position in the underbanked category. CDLX stock is deemed a 'Strong Buy'.
4
1
$Cardlytics(CDLX.US$ Clifford Sosin, 10% Owner, around March 15, 2024, executed a purchase for 661,715 shares in Cardlytics (CDLX) for $8,963,859. Following the Form 4 filing with the SEC, Sosin has control over a total of 6,023,676 shares of the company, with 6,023,676 shares controlled indirectly.
Read more